CGTX
COGNITION THERAPEUTICS INC
+0.05 (+4.90%)1.07USD221K成交股數102M市值–本益比(近四季)–股價營收比–營收年增(近四季)–下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | – | – | – | – | – | −10K | −2K | −6K | −10K |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 5.1M | 6.1M | 3.8M | 11.5M | 10.8M | 8.2M | 11.4M | 11.6M | 10.6M | 11.7M | 8.5M | 5.4M |
| 銷售管理費用 | 2.6M | 2.7M | 2.6M | 2.5M | 3.0M | 2.6M | 3.1M | 3.1M | 3.5M | 3.1M | 3.3M | 3.5M |
| 營業利益 | −7.7M-44% | −8.8M-18% | −6.4M-56% | −14.0M-5% | −13.8M-2% | −10.7M-27% | −14.5M+22% | −14.7M+64% | −14.1M | −14.7M | −11.8M | −9.0M |
| 營業利益率 | – | – | – | – | – | – | – | – | 141,020.0% | 737,250.0% | 196,950.0% | 89,730.0% |
| 稅後淨利 | −3.9M-54% | −4.6M-42% | −4.9M-50% | −6.7M-4% | −8.5M-7% | −7.8M+16% | −9.9M+110% | −7.0M+14% | −9.2M | −6.7M | −4.7M | −6.2M |
| 淨利率 | – | – | – | – | – | – | – | – | 91,510.0% | 337,450.0% | 78,766.7% | 61,720.0% |
| 稀釋 EPS | -0.04-71% | -0.05-69% | -0.06-76% | -0.11-39% | -0.14-48% | -0.16-27% | -0.25+56% | -0.18-14% | -0.27 | -0.22 | -0.16 | -0.21 |
| 稀釋股數 | 90.6M | 89.2M | 78.0M | 63.7M | 61.8M | 39.7M | 40.4M | 40.1M | 33.7M | 30.4M | 29.6M | 29.1M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 34.0M | 31.1M | 39.3M | 10.7M | 16.4M | 25.0M | 22.0M | 28.5M | 34.7M | 33.0M | 37.2M | 38.8M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 38.9M | 36.1M | 43.4M | 19.6M | 23.5M | 30.2M | 27.6M | 34.4M | 38.9M | 38.8M | 44.0M | 45.7M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 5.9M | 6.2M | 6.9M | 12.6M | 11.2M | 11.5M | 13.1M | 11.4M | 10.0M | 9.8M | 9.6M | 9.9M |
| 股東權益 | 33.0M | 29.9M | 36.5M | 7.0M | 12.3M | 18.8M | 14.5M | 23.0M | 28.9M | 28.9M | 34.4M | 35.8M |
| 負債比 | 15.1% | 17.2% | 15.8% | 64.2% | 47.8% | 38.0% | 47.5% | 33.1% | 25.7% | 25.4% | 21.8% | 21.6% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −5.5M | – | – | −9.9M+36% | – | – | – | −7.2M | – | – | −2.7M |
| 資本支出 | – | – | – | – | – | – | – | – | – | – | – | 41K |
| 自由現金流 | – | – | – | – | – | – | – | – | – | – | – | −2.7M |
| 折舊攤銷 | – | – | – | – | – | – | – | – | 27K | – | – | 21K |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | 27,460.0% |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | – | – | −23.5M | –% | -0.32 | – |
| FY2024 | – | – | −34.0M | –% | -0.86 | −28.5M |
| FY2023 | −27K | -3.6% | −25.8M | 95,511.1% | -0.86 | −16.2M |
| FY2022 | −28K | -96.9% | −21.4M | 76,417.9% | -0.91 | −18.7M |
| FY2021 | −893K | -49.0% | −11.7M | 1,312.0% | -3.13 | −3.7M |
| FY2020 | −1.8M | – | −7.8M | 447.7% | -23.76 | −3.4M |